Glipizide and Tykerb drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glipizide (glipizide) and Tykerb (lapatinib ditosylate). Common drug interactions include device related infection among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Glipizide and Tykerb. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

What is Tykerb?

Tykerb has active ingredients of lapatinib ditosylate. It is often used in breast cancer. eHealthMe is studying from 12,231 Tykerb users. Check the latest studies of Tykerb.



On Aug, 01, 2026

30 people who take Glipizide and Tykerb together, and have interactions are studied.

Glipizide and Tykerb drug interactions.

What are the common drug interactions of Glipizide and Tykerb, by gender? *:

female:

  1. Device related infection
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Dyspnoea (difficult or laboured respiration)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Electrolyte imbalance
  6. Erythema (redness of the skin)
  7. Fatigue (feeling of tiredness)
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Hepatic steatosis (fatty liver disease)

male:

  1. Death
  2. Pneumonia
  3. Bone disorder
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. C-reactive protein increased
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Constipation
  8. Cough
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Glipizide and Tykerb, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Adnexa uteri mass (ovarian cysts)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Back pain
  7. Blood creatine phosphokinase mb increased
  8. Bone disorder
  9. C-reactive protein increased
  10. Constipation

40-49:

  1. Diarrhoea
  2. Dizziness
  3. Dyspepsia (indigestion)
  4. Local swelling (swelling at the site of some application of substance or injury)
  5. Nausea (feeling of having an urge to vomit)
  6. Rash pruritic (redness with itching)
  7. Skin chapped
  8. Somnolence (a state of near-sleep, a strong desire for sleep)

50-59:

  1. Epistaxis (bleed from the nose)
  2. Fatigue (feeling of tiredness)
  3. Gingival bleeding (bleeding gums)
  4. Headache (pain in head)
  5. Ill-defined disorder
  6. Insomnia (sleeplessness)
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Nausea (feeling of having an urge to vomit)
  9. Rash
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

60+:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Hypoglycaemia (deficiency of glucose in the bloodstream)
  3. Ascites (accumulation of fluid in the abdominal cavity)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Back pain
  6. Blood creatine phosphokinase mb increased
  7. Bone disorder
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. C-reactive protein increased
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 6 people, 20.00%
  2. Meningioma Malignant (cancerous tumour of membranes that cover the brain and spinal cord just inside the skull): 2 people, 6.67%
  3. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide and Tykerb?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glipizide and Tykerb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tykerb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glipizide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tykerb and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on glipizide and lapatinib ditosylate (the active ingredients of Glipizide and Tykerb, respectively), and Glipizide and Tykerb (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: